[1]
|
Jokar, M., et al. (2023) Diagnosing Parkinson’s Disease by Combining Neuromelanin and Iron Imaging Features Using an Automated Midbrain Template Approach. NeuroImage, 266, Article ID: 119814.
https://doi.org/10.1016/j.neuroimage.2022.119814
|
[2]
|
Becker, G., Seufert, J., Bogdahn, U., Reichmann, H. and Reiners, K. (1995) Degeneration of Substantia Nigra in Chronic Parkinson’s Disease Visualized by Transcranial Col-or-Coded Real-Time Sonography. Neurology, 45, 182-184.
https://doi.org/10.1212/WNL.45.1.182
|
[3]
|
Berardelli, A., et al. (2013) EFNS/MDS-ES Recommendations for the Diagnosis of Parkinson’s Disease. European Journal of Neurology, 20, 16-34. https://doi.org/10.1111/ene.12022
|
[4]
|
Li, J., Jin, M., Wang, L., Qin, B. and Wang, K. (2017) MDS Clinical Di-agnostic Criteria for Parkinson’s Disease in China. Journal of Neurology, 264, 476-481. https://doi.org/10.1007/s00415-016-8370-2
|
[5]
|
Zhang, S., et al. (2020) Substantia Nigra Hyperechogenicity Re-flects the Progression of Dopaminergic Neurodegeneration in 6-OHDA Rat Model of Parkinson’s Disease. Frontiers in Cellular Neuroscience, 14, Article 216.
https://doi.org/10.3389/fncel.2020.00216
|
[6]
|
Yuan, J., et al. (2022) Controlled Activation of TRPV1 Channels on Microglia to Boost Their Autophagy for Clearance of Alpha-Synuclein and Enhance Therapy of Parkinson’s Disease. Advanced Materials, 34, e2108435.
https://doi.org/10.1002/adma.202108435
|
[7]
|
Li, K., et al. (2020) Substantia Nigra Echogenicity Is Associated with Serum Ferritin, Gender and Iron-Related Genes in Parkinson’s Disease. Scientific Reports, 10, Article No. 8660. https://doi.org/10.1038/s41598-020-65537-5
|
[8]
|
Ahmadi, S.-A., et al. (2020) Analyzing the CO-Localization of Substantia Nigra Hyper-Echogenicities and Iron Accumulation in Parkinson’s Disease: A Multi-Modal Atlas Study with Transcranial Ultrasound and MRI. NeuroImage: Clinical, 26, Article ID: 102185. https://doi.org/10.1016/j.nicl.2020.102185
|
[9]
|
Lin, Z.-H., et al. (2022) Quercetin Protects against MPP+/MPTP-Induced Dopaminergic Neuron Death in Parkinson’s Disease by Inhibiting Ferroptosis. Oxidative Medi-cine and Cellular Longevity, 2022, Article ID: 7769355.
https://doi.org/10.1155/2022/7769355
|
[10]
|
Yilmaz, R. and Berg, D. (2018) Transcranial B-Mode Sonography in Movement Disorders. International Review of Neurobiology, 143, 179-212. https://doi.org/10.1016/bs.irn.2018.10.008
|
[11]
|
Becker, T., et al. (1997) Parkinson’s Disease and Depression: Evi-dence for an Alteration of the Basal Limbic System Detected by Transcranial Sonography. Journal of Neurology, Neuro-surgery & Psychiatry, 63, 590-596.
https://doi.org/10.1136/jnnp.63.5.590
|
[12]
|
Fischer, N.M., et al. (2021) Brainstem Pathologies Correlate with De-pression and Psychosis in Parkinson’s Disease. The American Journal of Geriatric Psychiatry, 29, 958-968. https://doi.org/10.1016/j.jagp.2020.12.009
|
[13]
|
Bei, H.-Z., et al. (2020) Echogenicity Changes in Brainstem Raphe Detected by Transcranial Parenchymal Sonography and Clinical Characteristics in Parkinson’s Disease. Frontiers in Neurology, 11, Article 821.
https://doi.org/10.3389/fneur.2020.00821
|
[14]
|
Liu, X.J., et al. (2018) Echogenic Alteration in the Raphe Nuclei Measured by Transcranial Sonography in Patients with Parkinson Disease and Depression. Medicine, 97, e13524. https://doi.org/10.1097/MD.0000000000013524
|
[15]
|
Tao, A., et al. (2020) Essential Tremor vs Idiopathic Parkin-son Disease: Utility of Transcranial Sonography. Medicine, 99, e20028. https://doi.org/10.1097/MD.0000000000020028
|
[16]
|
Wang, L.-S., Yu, T.-F., Chai, B. and He, W. (2021) Tran-scranial Sonography in Differential Diagnosis of Parkinson Disease and Other Movement Disorders. Chinese Medical Journal, 134, 1726-1731.
https://doi.org/10.1097/CM9.0000000000001503
|
[17]
|
Behnke, S., et al. (2019) Third Ventricular Width Assessed by Transcranial Ultrasound Correlates with Cognitive Performance in Parkinson’s Disease. Parkinsonism & Related Disorders, 66, 68-73.
https://doi.org/10.1016/j.parkreldis.2019.07.005
|
[18]
|
Walter, U., et al. (2007) Transcranial Brain Sonography Findings in Discriminating between Parkinsonism and Idiopathic Parkinson Disease. Archives of Neurology, 64, 1635-1640. https://doi.org/10.1001/archneur.64.11.1635
|
[19]
|
Cheng, L., et al. (2020) Discriminative Pattern of Reduced Cerebral Blood Flow in Parkinson’s Disease and Parkinsonism-Plus Syndrome: An ASL-MRI Study. BMC Medical Imaging, 20, Article No. 78.
https://doi.org/10.1186/s12880-020-00479-y
|
[20]
|
Skoloudik, D., et al. (2020) Digitized Image Analysis of Insula Echogenicity Detected by TCS-MR Fusion Imaging in Wilson’s and Early-Onset Parkinson’s Diseases. Ultrasound in Medicine and Biology, 46, 842-848.
https://doi.org/10.1016/j.ultrasmedbio.2019.12.013
|
[21]
|
Skowronska, M., Litwin, T., Kurkowska-Jastrzębska, I. and Członkowska, A. (2020) Transcranial Sonography Changes in Heterozygotic Carriers of the ATP7B Gene. Neuro-logical Sciences, 41, 2605-2612.
https://doi.org/10.1007/s10072-020-04378-6
|
[22]
|
Godau, J., et al. (2008) Sonographic Abnormalities of Brainstem Structures in Restless Legs Syndrome. Sleep Medicine, 9, 782-789. https://doi.org/10.1016/j.sleep.2007.09.001
|
[23]
|
Zareba, M., Furman, W. and Binder, M. (2022) Influence of Age and Cognitive Performance on Resting-State Functional Connectivity of Dopaminergic and Noradrenergic Centers. Brain Research, 1796, Article ID: 148082.
https://doi.org/10.1016/j.brainres.2022.148082
|
[24]
|
Eisenberg, D.P., et al. (2022) Comparison of Transcranial So-nography and [18F]-Fluorodopa PET Imaging in GBA1 Mutation Carriers. Movement Disorders, 37, 629-634. https://doi.org/10.1002/mds.28852
|
[25]
|
Ghanouni, P., et al. (2015) Transcranial MRI-Guided Focused Ultrasound: A Review of the Technologic and Neurologic Applications. American Journal of Roentgenology, 205, 150-159. https://doi.org/10.2214/AJR.14.13632
|